- Headquarters
- Seongnam-Si
- Founded
- 2016
- Business Model
- B2B
- Website
- tiumbio.com
- Last Round
- Series BJan 2016
- Rounds
- 1
About
South Korean biotech developing immuno-oncology therapeutics for cancer treatment.
Summary
Tium Bio is a Biotech company based in Seongnam-Si, South Korea, founded in 2016. Its most recent funding was a Series B round in Jan 2016. Investors include IMM Investment and KIP Global Pharma Private Equity Fund.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2016
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...